Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis

Whether macrolide combination therapy reduces the mortality of patients with severe community-acquired pneumonia (CAP) hospitalized in the non-intensive care unit (ICU) remains unclear. Therefore, we investigated the efficacy of adding azithromycin to β-lactam antibiotics for such patients. This pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Akihiro, Ishida, Tadashi, Tachibana, Hiromasa, Tokumasu, Hironobu, Yamazaki, Akio, Washio, Yasuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895050/
https://www.ncbi.nlm.nih.gov/pubmed/31804572
http://dx.doi.org/10.1038/s41598-019-54922-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895050/
https://www.ncbi.nlm.nih.gov/pubmed/31804572
http://dx.doi.org/10.1038/s41598-019-54922-4

Ejemplares similares